Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Late Isolated Extramedullary Relapse From Acute Lymphoblastic Leukemia (ALL) (Initial CR1≥ 18 Months)

NCT00096135 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00096135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00096135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Late Isolated Extramedullary Relapse From Acute Lymphoblastic Leukemia (ALL) (Initial CR1≥ 18 Months)
Lead sponsor
Children's Oncology Group
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2004
Completion date
Not reported
Enrollment
168 (actual)
Sites
153

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia